Table 2:

Imaging characteristics and treatment

Fragmented Thrombus (n = 24) (7.4%)Single Thrombus (n = 300) (92.6%)P
Affected vascular territory.739
    Anterior circulation (No.) (%)21 (87.5)267 (89.0)
    Posterior circulation (No.) (%)3 (12.5)33 (11.0)
Occlusion site.372
    Tandem occlusion (No.) (%)3 (12.5)29 (9.7)
    Carotid-T (No.) (%)3 (12.5)14 (4.7)
    MCA M1 (No.) (%)8 (33.3)123 (41.0)
    MCA M2 (No.) (%)6 (25.0)74 (24.7)
    MCA M3/4 (No.) (%)1 (4.2)23 (7.7)
    Anterior cerebral artery (No.) (%)0 (0.0)4 (1.3)
    Basilar artery (No.) (%)3 (12.5)16 (5.3)
    Posterior cerebral artery (No.) (%)0 (0.0)17 (5.7)
Primary thrombus length on SWI (mm) (mean) (SD)10.3 (6.4) (n = 18)10.3 (5.6) (n = 248).699
Total clot length (mm) (mean) (SD)20.1 (10.7) (n = 18)10.3 (5.6) (n = 248)<.001
DWI ASPECTS (media) (range)5 (0–8) (n = 21)7 (0–10) (n = 263).006
Leptomeningeal collateralsn = 19n = 199.051
    Good (No.) (%)4 (21.1)88 (44.2)
    Moderate/poor (No.) (%)15 (78.9)111 (55.8)
Treatment.625
    Intravenous thrombolysis only (No.) (%)6 (25.0)102 (34.0)
    Bridging thrombolysis (No.) (%)7 (29.2)69 (23.0)
    Endovascular intervention only (No.) (%)11 (45.8)129 (43.0)